Edinburgh Clinical Trials

ABC Sepsis

Feasibility of 5% Albumin compared with Balanced Crystalloid, as intravenous fluid resuscitation in adult patients with sepsis, presenting as an emergency to hospital

The aim of this research study is to compare two different fluids (Human Albumin Solution (HAS) and Balanced Crystalloid that are given via a drip to patients with severe infection (sepsis). We plan to see which fluid is better, and to see if they have a role in improving a patient’s recovery time, reducing complications and the length of time they stay in hospital. This study plans to find out if one fluid is better overall than the other before completing a larger research study.

 

Chief Investigator: Prof Alasdair Gray  

ABC Sepsis

Number and location of participating sites (by region/ country):

10 UK Sites

EudraCT number: 2020-01352-18

ISRCTN number:  TBC

Funder: J P Moulton Charitable Foundation

Start and End date

Of grant award: 01 Jul 2020

Of recruitment: 01 Jan 2021

 

 

Current Status: In Set Up

Trial Website: No

Email: abcsepsis.trial@ed.ac.uk

 

GDPR Privacy Statement: TBC

 

Sponsor: ACCORD (https://www.accord.ed.ac.uk/)

Chief Investigator:

Prof Alasdair Gray Address:    Emergency Medicine Research Group (EMERGE) Department of Emergency Medicine Royal Infirmary of Edinburgh 51 Little France Crescent Edinburgh, EH16 4SA

Email: Alasdair.gray@ed.ac.uk

 

Trial Manager: Kat Oatey Email: abcsepsis.trial@ed.ac.uk

 

Research nurse: Julia Grahamslaw Email: Julia.grahamslaw@nhslothian.scot.nhs.uk

 

 

ECTU involvement: Trial management / Statistics / Health Economics / Data base